Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-24

Clinical Trial Update: Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1 [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating ursodeoxycholic acid combined with total glucosides of paeony for primary biliary cholangitis with autoimmune features.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Total Glucosides of Paeony (total glucosides of paeony)
  • Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: West China Hospital | Conditions: Hepatitis, Primary Biliary Cholangitis | Phase 4 | Status: UNKNOWN